{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T18:31:48Z","timestamp":1648578708099},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1007\/bf03191307","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T03:00:11Z","timestamp":1281841211000},"page":"77-80","source":"Crossref","is-referenced-by-count":2,"title":["Passage of allophanoyl-gamma-lactones through the kidney"],"prefix":"10.1007","volume":"13","author":[{"given":"Olivier","family":"Lafont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Cave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Menager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Lambrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Miocque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03191307_CR1","first-page":"579","volume":"9","author":"B. Bobranski","year":"1961","unstructured":"Bobranski B., Syper L. (1961): Studies of the metabolism of 5-allyl-5-(-hydroxypropyl)-barbituric acid in the human body. Arch. Immunol. ITerapii Dosw. 9: 579\u2013591.","journal-title":"Arch. Immunol. ITerapii Dosw."},{"key":"BF03191307_CR2","first-page":"475","volume":"8","author":"B. Bobranski","year":"1960","unstructured":"Bobranski B., Prelicz D., Syper L., Wojtowski R. (1960): On the isomerisation of 5-allyl-5-(-hydroxypropyl)-barbituric acid. Bull. Acad. Pol. Sci. 8: 475\u2013479.","journal-title":"Bull. Acad. Pol. Sci."},{"key":"BF03191307_CR3","first-page":"672","volume":"13","author":"B. Bobranski","year":"1965","unstructured":"Bobranski B., Syper L., Witon J. (1965): Metabolism of-allyl-allophany-valerolactone. Arch. Immunol. Ther. Exp. (Warsz) 13: 672\u2013675.","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"BF03191307_CR4","first-page":"51","volume":"36","author":"T. Hermann","year":"1979","unstructured":"Hermann T., Kulbiej J. (1979): Kinetics and mechanism of decomposition of some derivatives of 5-allylbarbituric acid IV. Dependence of kinetics of solvolysis of 5-allyl-5-(21hydroxypropyl)-barbituric acid upon pH. Acta Pol. Pharm. 36: 51\u201359.","journal-title":"Acta Pol. Pharm."},{"key":"BF03191307_CR5","first-page":"79","volume":"55","author":"E.L. Frochaux-Zeidler","year":"1980","unstructured":"Frochaux-Zeidler E.L., Testa B. (1980): Metabolic investigations of Proxibarbal, 5-allyl-5-(2-hydroxypropyl)-barbituric acid in vitro. Pharm. Acta Helv. 55: 79\u201383.","journal-title":"Pharm. Acta Helv."},{"key":"BF03191307_CR6","first-page":"143","volume":"14","author":"0. Lafont","year":"1979","unstructured":"Lafont 0., Lambrey B., Jacquot C, Rapin J.R., d\u2019Athis Ph., de Lauture D. (1979): Etude pharmacocin\u00e9tique et chimique de l\u2019\u00e9quilibre entre un barbiturique-alcohol: l\u2019acide allyl-5-(hydroxy-2-propyl)-5-barbiturique et le monour\u00e9ide lactonique correspondant. Eur. J. Med. Chem. 14: 143\u2013150.","journal-title":"Eur. J. Med. Chem."},{"key":"BF03191307_CR7","first-page":"463","volume":"15","author":"B. Lambrey","year":"1980","unstructured":"Lambrey B., Lafont 0., Jacquot C. (1980): Etude des produits d\u2019excr\u00e9tion urinaire du proxibarbal chez le rat et l\u2019homme. Eur. J. Med. Chem. 15: 463\u2013468.","journal-title":"Eur. J. Med. Chem."},{"key":"BF03191307_CR8","first-page":"181","volume":"17","author":"0. Lafont","year":"1982","unstructured":"Lafont 0., Lambrey B., d\u2019Athis Ph., de Lauture D., Jacquot C. (1982): Etude in vivo et in vitro de la formation d\u2019ur\u00e9e \u00e0 partir d\u2019un barbiturique \u03c9-1 hydroxyl\u00e9: le Proxibarbal. Eur. J. Med. Chem. 17: 181\u2013186.","journal-title":"Eur. J. Med. Chem."},{"key":"BF03191307_CR9","first-page":"163","volume":"18","author":"0. Lafont","year":"1983","unstructured":"Lafont 0., Cav\u00e9 C, Lambrey B., Briffaux J.P., Jacquot C, Miocque M. (1983): Etude chimique et m\u00e9tabolique de l\u2019acide (hydroxy-2-propyl)-5-(m\u00e9thyl-2-propyl)-5-barbiturique: r\u00f4le de la fonction alcohol en\u00f4. Eur. J. Med. Chem. 18; 163\u2013168.","journal-title":"Eur. J. Med. Chem."},{"key":"BF03191307_CR10","first-page":"17","volume":"19","author":"0. Lafont","year":"1984","unstructured":"Lafont 0., Cav\u00e9 C, Lambrey B., Monnot G., Jacquot C, Miocque M. (1984): Comportement in vivo et in vitro de l\u2019allophanyl-2-(m\u00e9thyl-2-propyl)-2-valerolactone: comparaison avec l\u2019hydroxybarbiturique correspondant. Eur. J. Med. Chem. 19; 17\u201321.","journal-title":"Eur. J. Med. Chem."},{"key":"BF03191307_CR11","first-page":"339","volume":"20","author":"0. Lafont","year":"1985","unstructured":"Lafont 0., Cav\u00e9 C, Lambrey B., M\u00e9nager S., Miocque M. (1985): Amobarbital, formation et \u00e9tude de l\u2019\u00e9volution de ses derives hydroxyl\u00e9s in vitro et in vivo chez le chien. Eur. J. Med. Chem. 20; 339\u2013344.","journal-title":"Eur. J. Med. Chem."},{"key":"BF03191307_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03189614","volume":"9","author":"H.H. Wittekind","year":"1984","unstructured":"Wittekind H.H., Testa B., Balant L.P. (1984): Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study. Eur. J. Drug. Metab. Pharmacokin. 9: 117\u2013122.","journal-title":"Eur. J. Drug. Metab. Pharmacokin."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03191307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03191307\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03191307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:07:46Z","timestamp":1558483666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03191307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["BF03191307"],"URL":"https:\/\/doi.org\/10.1007\/bf03191307","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}